Summary
This prediction ended on 24.06.22 with a price of €57.79. With a performance of -7.73%, the BUY prediction for Bayer AG by Mori8 closed slightly in the red. Mori8 has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -5.640% | -5.640% | 66.058% | -35.787% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % | 50,71 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % | 102,82 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % | 64,80 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % | 70,25 % |
Comments by Mori8 for this prediction
In the thread Bayer AG diskutieren
Buy Bayer AG
11:58 | UBS stuft BAYER AG auf 'Buy' | 334 |
09:10 | BARCLAYS stuft BAYER AG auf 'Overweight' | 397 |
Di | JPMORGAN stuft BAYER AG auf 'Overweight' | 802 |
Di | JEFFERIES stuft BAYER AG auf 'Buy' | 959 |
Di | BARCLAYS stuft BAYER AG auf 'Overweight'
09:10 | BARCLAYS stuft BAYER AG auf 'Overweight' | 397 |
Di | JPMORGAN stuft BAYER AG auf 'Overweight' | 802 |
Di | JEFFERIES stuft BAYER AG auf 'Buy' | 959 |
Di | BARCLAYS stuft BAYER AG auf 'Overweight'